![Yong Huang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yong Huang
Vorstandsvorsitzender bei Optivia Biotechnology, Inc.
Ursprung des Netzwerks ersten Grades von Yong Huang
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Optivia Biotechnology, Inc.
![]() Optivia Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Optivia Biotechnology, Inc. provides contract research organization offering drug transporter research services and solutions to biotechnology, pharmaceutical and academic organizations. It offers regulatory DDI studies, transporter screening, tranporter profiling, and custom development services. The firm's products include TransFlex Single Transporter Assay Plates,TransFlex Multi-Transporter Model Plates, and Certified Efflux Transporter Vesicles. The company was founded by Yong Huang, Pascal Druzgala and Peter G. Milner in 2007 and is headquartered in Santa Clara, CA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Yong Huang
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Renexxion LLC
![]() Renexxion LLC Pharmaceuticals: MajorHealth Technology Renexxion LLC is a gastrointestinal biopharmaceutical company. It develops naronapride. The company was founded by Peter G. Milner, Muralitharan Kengatharan , and Pascal J. Druzgala in 2014 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Founder Founder | |
ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder | |
Armetheon, Inc.
![]() Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA. | Pharmaceuticals: Major | Founder Founder | |
The University of Liverpool
![]() The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Bay City Capital LLC
![]() Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Corporate Officer/Principal | |
WUXI APPTEC CO., LTD. | Pharmaceuticals: Major | Chairman | |
Stanford University | College/University | Doctorate Degree | |
Advent International LP
![]() Advent International LP Investment ManagersFinance Advent International LP (Advent) is an independent private equity firm founded in 1984 by Henry H. Haight. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Advanced Therapies, Inc. | Founder | ||
NEURONAX SA
![]() NEURONAX SA Pharmaceuticals: MajorHealth Technology NEURONAX SA develops and provides drugs supporting neural repair to treat degenerative disorders of the central nervous system. Its services include cell culture, in vitro evaluation, neurotrophic and neuroprotective effects analysis, culture analyses, and stem cells. The company was founded by Stéphane Gobron, Fabrice Cailloux, and Pierre-Yves Simonin in 2003 and is headquartered in Saint-Beauzire, France. | Pharmaceuticals: Major | Director/Board Member | |
Diaccurate SA
![]() Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Sibylla Biotech Srl
![]() Sibylla Biotech Srl Internet Software/ServicesTechnology Services Sibylla Biotech Srl engages in research and development activities in the pharmaceutical sector. It specializes in studies through its proprietary atom computer simulations for new drug discoveries. The company was founded by Maria Letizia Barreca and Emiliano Biasini in 2017 and is headquartered in Trento, Italy. | Internet Software/Services | Chairman | |
Université Paris-Saclay | College/University | Doctorate Degree | |
Pappas Capital LLC
![]() Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Investment Managers | Corporate Officer/Principal | |
University of Florida | College/University | Doctorate Degree | |
Xenon Vision, Inc.
![]() Xenon Vision, Inc. Miscellaneous Commercial ServicesCommercial Services Part of W World Corp., Xenon Vision, Inc. is a vision research concern. The company is based in Alachua, FL. Xenon Vision was acquired by Pharmatec, Inc. on November 03, 1992. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Université de Montpellier | College/University | Doctorate Degree | |
Ischemix, Inc.
![]() Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Pharmaceuticals: Major | Director/Board Member | |
Retrotope, Inc.
![]() Retrotope, Inc. Pharmaceuticals: MajorHealth Technology Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Director/Board Member | |
AshHill Investments LLC
![]() AshHill Investments LLC Investment ManagersFinance AshHill Investments LLC (AshHill Investments) is a venture capital firm founded in 2011. The firm is headquartered in Ft. Thomas, Kentucky. | Investment Managers | Chief Executive Officer | |
SinuSys Corp.
![]() SinuSys Corp. Medical SpecialtiesHealth Technology SinuSys Corp. develops medical device therapies to improve the sinus health of patients with chronic sinusitis. Its products include Vent-OS sinus dilation system, Restora steroid-eluting spacer, and SinuSys product pipeline. The company was founded by Jerome Hester and Thomas A. Schreck in 2010 and is headquartered in Palo Alto, CA. | Medical Specialties | Director/Board Member | |
TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
Washington University in St. Louis | College/University | Corporate Officer/Principal | |
Lifeline Technologies, Inc.
![]() Lifeline Technologies, Inc. BiotechnologyHealth Technology Lifeline Technologies, Inc. operates as a health sciences development company which focuses on novel strategies. It offers ChoLESStolife, a non-prescription and non-synthetic cholesterol absorption inhibitor for the reduction of human cholesterol using a fat-free delivery system for soy sterols and stanols. The company was registered by Curtis A. Spilburg and Richard E. Ostlund on October 1, 2002 and is headquartered in Hendersonville, NC. | Biotechnology | Director/Board Member | |
ABV LLC
![]() ABV LLC Investment ManagersFinance ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
École Nationale Supérieure de Chimie de Paris | College/University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 23 |
Frankreich | 6 |
Vereinigtes Königreich | 3 |
China | 2 |
Italien | 2 |
Sektoral
Health Technology | 17 |
Consumer Services | 9 |
Finance | 6 |
Commercial Services | 3 |
Technology Services | 2 |
Operativ
Director/Board Member | 19 |
Founder | 13 |
Corporate Officer/Principal | 9 |
Chief Tech/Sci/R&D Officer | 9 |
Chief Executive Officer | 6 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Peter G. Milner | 18 |
Pascal J. Druzgala | 9 |
Charles Hsu | 8 |
Dominique Bridon | 7 |
Per Artursson | 1 |
- Börse
- Insiders
- Yong Huang
- Unternehmensverbindungen